Compugen Ltd
CGEN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001119774
In the last 90 days, Compugen Ltd insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Compugen Ltd as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 90
- −18 vs. Q1 2022
- Shares held
- 37.9M
- −3.93M (−9.4%) vs. Q1 2022
- Total value
- $70.1M
- −$64.6M (−48.0%) vs. Q1 2022
- New holders
- 7
- 16 more added
- Sold out
- 25
- 35 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 83 | $30.3M |
| Q1 2026 | 79 | $30.3M |
| Q4 2025 | 73 | $19.3M |
| Q3 2025 | 69 | $18.3M |
| Q2 2025 | 70 | $26.8M |
| Q1 2025 | 71 | $22.1M |
| Q4 2024 | 70 | $18.6M |
| Q3 2024 | 65 | $21.7M |
| Q2 2024 | 66 | $20.7M |
| Q1 2024 | 74 | $33.0M |
| Q4 2023 | 73 | $21.5M |
| Q3 2023 | 66 | $11.7M |
| Q2 2023 | 69 | $13.1M |
| Q1 2023 | 68 | $7.68M |
| Q4 2022 | 74 | $11.6M |
| Q3 2022 | 81 | $14.5M |
| Q2 2022 | 90 | $70.1M |
| Q1 2022 | 110 | $135.3M |
| Q4 2021 | 114 | $147.1M |
| Q3 2021 | 108 | $210.8M |
| Q2 2021 | 108 | $305.7M |
| Q1 2021 | 109 | $344.0M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Compugen Ltd; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jump Financial, LLC | 0 | $0 | 0.00% | −48,200−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −37,909−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −26,513−100.0% | Sold out |
| Van Eck Associates Corp | 0 | $0 | 0.00% | −21,426−100.0% | Sold out |
| Pinnacle Associates Ltd | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −18,581−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −18,250−100.0% | Sold out |
| Pictet Asset Management SA | 0 | $0 | 0.00% | −16,538−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −14,016−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −12,783−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,464−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −10,403−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −10,111−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −9,556−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |